Search Results

A controlled, randomized phase II clinical trial for efficacy and safety evaluation of mannuronic acid in secondary progressive form of multiple sclerosis.

• Authors : Najafi, Soheil (AUTHOR); Moghadam, Nahid Beladi (AUTHOR); Saadat, Payam (AUTHOR)

Subjects: MULTIPLE sclerosis; INTERFERON beta 1b; CLINICAL trials

• Source: International Journal of Neuroscience. Apr2022, Vol. 132 Issue 4, p403-412. 10p.

Record details

Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients.

• Authors : Casanova, Bonaventura; Lacruz, Laura; Villar, María Luisa

Subjects: GLATIRAMER acetate; INTERFERON beta 1b; DRUG efficacy

• Source: Neurological Sciences. Aug2018, Vol. 39 Issue 8, p1423-1430. 8p. 1 Diagram, 2 Charts, 4 Graphs.

Record details

Fingolimod: Lymphoproliferative disorder: case report.

Subjects: *INTERFERON beta 1b; *INTERFERON beta-1a; *LYMPHOPROLIFERATIVE disorders

• Source: Reactions Weekly. 8/31/2024, Vol. 2023 Issue 1, p171-171. 1p.

Record details

Thrombotic microangiopathy due to acquired complement factor I deficiency in a male receiving interferon‐beta treatment for multiple sclerosis.

• Authors : Mrabet, Sanda¹ (AUTHOR) ; Dahmane, Rihem¹ (AUTHOR); Raja, Boukadida¹ (AUTHOR)

Subjects: *ECULIZUMAB; *INTERFERON beta 1b; *MULTIPLE sclerosis

• Source: British Journal of Clinical Pharmacology. May2023, Vol. 89 Issue 5, p1682-1685. 4p.

Record details

Therapeutic effect of Avonex, Rebif and Betaferon on quality of life in multiple sclerosis.

• Authors : Mokhber, Naghmeh; Azarpazhooh, Amir; Orouji, Elias

Subjects: INTERFERON beta-1a; INTERFERON beta 1b; QUALITY of life

• Source: Psychiatry & Clinical Neurosciences. Oct2015, Vol. 69 Issue 10, p649-657. 9p. 1 Diagram, 1 Chart, 2 Graphs.

Record details

Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex).

• Authors : Cohan, Stanley L. (AUTHOR); Hendin, Barry A. (AUTHOR); Reder, Anthony T. (AUTHOR)

Subjects: INTERFERON beta-1a; INTERFERON beta 1b; MEDICAL personnel

• Source: CNS Drugs. Jul2021, Vol. 35 Issue 7, p743-767. 25p.

Record details

Interferon-beta injection site reactions in patients with multiple sclerosis.

• Authors : Maurelli, Martina¹; Bergamaschi, Roberto²; Antonini, Ambra³

Subjects: *MULTIPLE sclerosis treatment; *INTERFERON beta 1b; *INTRAMUSCULAR injections

• Source: Journal of Dermatological Treatment. Dec2018, Vol. 29 Issue 8, p831-834. 4p.

Record details

EE333 Evaluating the Long-Term Clinical, Societal, and Economic Outcomes of Ofatumumab vs Teriflunomide/Interferon Β-1A and the Impact of Early vs Delayed Ofatumumab Initiation in Relapsing Multiple Sclerosis Patients in Greece.

• Authors : Petropoulos, A¹ (AUTHOR); Vudumula, U² (AUTHOR); Patidar, M³ (AUTHOR)

Subjects: *INTERFERON beta 1b; *MULTIPLE sclerosis; *INTERFERONSGREECE

• Source: Value in Health. 2022 Suppl, Vol. 25 Issue 12, pS119-S120. 2p.

Record details

Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study.

• Authors : Naismith, Robert T. (AUTHOR); Wundes, Annette (AUTHOR); Ziemssen, Tjalf (AUTHOR)

Subjects: INTERFERON beta 1b; MULTIPLE sclerosis; GLYCOPYRROLATE

• Source: CNS Drugs. Feb2020, Vol. 34 Issue 2, p185-196. 12p.

Record details

CCR5 Δ32 and CTLA-4 +49 A/G Gene Polymorphisms and Interferon-β Treatment Response in Croatian and Slovenian Multiple Sclerosis Patients.

• Authors : Nekić, Jasna¹ (AUTHOR) ; Stanković Matić, Ivana² (AUTHOR) ; Rački, Valentino^3,4 (AUTHOR)

Subjects: *INTERFERON beta 1b; *CYTOTOXIC T lymphocyte-associated molecule-4; *GENETIC polymorphismsCROATIA; SLOVENIA

• Source: International Journal of Molecular Sciences. Jul2024, Vol. 25 Issue 13, p7412. 11p.

Record details